[This corrects the article DOI: 10.3389/fonc.2023.1244628.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10867318 | PMC |
| http://dx.doi.org/10.3389/fonc.2024.1372295 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum bevacizumab-irinotecan
4
bevacizumab-irinotecan combination
4
combination therapy
4
therapy recurrent
4
recurrent low-grade
4
low-grade glioma
4
glioma treated
4
treated chemo-radiotherapy
4
chemo-radiotherapy case
4
case report
4
Similar Publications
Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report.
Front Oncol
February 2024
Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
[This corrects the article DOI: 10.3389/fonc.2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!